Aminologics Co.,Ltd. (KOSDAQ: 074430)

Aminologics Co.,Ltd. Statistics

Total Valuation

Aminologics Co.,Ltd. has a market cap or net worth of KRW 106.18 billion. The enterprise value is 74.18 billion.

Market Cap	106.18B
Enterprise Value	74.18B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Aminologics Co.,Ltd. has 87.83 million shares outstanding. The number of shares has decreased by -1.81% in one year.

Shares Outstanding	87.83M
Shares Change (YoY)	-1.81%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	0.31%
Float	59.89M

Valuation Ratios

The trailing PE ratio is 37.09.

PE Ratio	37.09
Forward PE	n/a
PS Ratio	4.64
PB Ratio	1.90
P/FCF Ratio	26.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.01, with an EV/FCF ratio of 18.64.

EV / Earnings	26.15
EV / Sales	3.27
EV / EBITDA	31.01
EV / EBIT	38.13
EV / FCF	18.64

Financial Position

The company has a current ratio of 11.64, with a Debt / Equity ratio of 0.04.

Current Ratio	11.64
Quick Ratio	9.73
Debt / Equity	0.04
Debt / EBITDA	0.89
Debt / FCF	0.54
Interest Coverage	27.77

Financial Efficiency

Return on equity (ROE) is 5.21% and return on invested capital (ROIC) is 2.16%.

Return on Equity (ROE)	5.21%
Return on Assets (ROA)	2.05%
Return on Capital (ROIC)	2.16%
Revenue Per Employee	596.38M
Profits Per Employee	74.65M
Employee Count	38
Asset Turnover	0.38
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.75%
50-Day Moving Average	1,231.08
200-Day Moving Average	1,407.87
Relative Strength Index (RSI)	52.66
Average Volume (20 Days)	640,243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aminologics Co.,Ltd. had revenue of KRW 22.66 billion and earned 2.84 billion in profits. Earnings per share was 32.60.

Revenue	22.66B
Gross Profit	8.09B
Operating Income	1.95B
Pretax Income	2.69B
Net Income	2.84B
EBITDA	2.39B
EBIT	1.95B
Earnings Per Share (EPS)	32.60

Balance Sheet

The company has 34.14 billion in cash and 2.13 billion in debt, giving a net cash position of 32.01 billion or 364.44 per share.

Cash & Cash Equivalents	34.14B
Total Debt	2.13B
Net Cash	32.01B
Net Cash Per Share	364.44
Equity (Book Value)	56.02B
Book Value Per Share	637.84
Working Capital	44.30B

Cash Flow

In the last 12 months, operating cash flow was 4.03 billion and capital expenditures -44.70 million, giving a free cash flow of 3.98 billion.

Operating Cash Flow	4.03B
Capital Expenditures	-44.70M
Free Cash Flow	3.98B
FCF Per Share	45.32

Margins

Gross margin is 35.70%, with operating and profit margins of 8.58% and 12.52%.

Gross Margin	35.70%
Operating Margin	8.58%
Pretax Margin	11.88%
Profit Margin	12.52%
EBITDA Margin	10.55%
EBIT Margin	8.58%
FCF Margin	17.56%

Dividends & Yields

Aminologics Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.81%
Shareholder Yield	1.81%
Earnings Yield	2.70%
FCF Yield	3.75%

Stock Splits

The last stock split was on October 23, 2009. It was a forward split with a ratio of 5.

Last Split Date	Oct 23, 2009
Split Type	Forward
Split Ratio	5

Scores

Aminologics Co.,Ltd. has an Altman Z-Score of 14.84.

Altman Z-Score	14.84
Piotroski F-Score	n/a